
Innovative Solutions Emerge for Safer Pain Management Beyond Opioids
A study by Weill Cornell Medicine suggests that boosting the endocannabinoid 2-AG in the brain can reduce opioid addiction without compromising pain relief. This approach, tested in mice using the chemical JZL184, may lead to safer pain management therapies by mitigating the addictive properties of opioids like morphine and oxycodone. The research highlights a potential new therapeutic strategy to address the opioid crisis, which has resulted in over 80,000 deaths in 2023 alone.
